Measures and predictors of community-based employment and earnings of persons with schizophrenia in a multisite study

被引:112
作者
Salkever, David S.
Karakus, Mustafa C.
Slade, Eric P.
Harding, Courtenay M.
Hough, Richard L.
Rosenheck, Robert A.
Swartz, Marvin S.
Barrio, Concepcion
Yamada, Anne Marie
机构
[1] Univ Maryland Baltimore Cty, Dept Publ Policy, Baltimore, MD 21205 USA
[2] Westat Corp, Rockville, MD USA
[3] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA
[4] Boston Univ, Inst Study Human Resilience, Boston, MA 02215 USA
[5] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA
[6] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
[7] Duke Univ, Dept Psychiat, Durham, NC 27706 USA
[8] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA
关键词
D O I
10.1176/appi.ps.58.3.315
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Data from a national study of persons with schizophrenia-related disorders were examined to determine clinical factors and labor-market conditions related to employment outcomes. Methods: Data were obtained from the U. S. Schizophrenia Care and Assessment Program, a naturalistic study of more than 2,300 persons from organized care systems in six U. S. regions. Data were collected via surveys and from medical records and clinical assessments at baseline and for three years. Outcome measures included any community-based (nonsheltered) employment, 40 or more hours of work in the past month, employment at or above the federal minimum wage, days and hours of work, and earnings. Bivariate and multiple regression analyses of data from more than 7,000 assessments tested relationships between outcomes and sociodemographic, clinical, and local labor market characteristics. Results: The employment rate was 17.2%; only 57.1% of participants who worked reported 40 or more hours of past-month employment. The mean hourly wage was $7.05, and mean monthly earnings were $494.20. Employment rates and number of hours worked were substantially below those found in household surveys or in baseline data from trials of employment programs but substantially higher than those found in a recent large clinical trial. Strong positive relationships were found between clinical factors and work outcomes, but evidence of a relationship between local unemployment rates and outcomes was weak. Conclusions: Work attachment and earnings were substantially lower than in previous survey data, not very sensitive to labor market conditions, and strongly related to clinical status.
引用
收藏
页码:315 / 324
页数:10
相关论文
共 38 条
[1]  
[Anonymous], PUB DEP HLTH HUM SER
[2]  
[Anonymous], 1976, ECDEU ASSESSMENT MAN
[3]   Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care [J].
Ascher-Svanum, H ;
Faries, DE ;
Zhu, BJ ;
Ernst, FR ;
Swartz, MS ;
Swanson, JW .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (03) :453-460
[4]  
Catalano Ralph, 1999, J Ment Health Policy Econ, V2, P51
[5]   Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness [J].
Cook, JA ;
Leff, HS ;
Blyler, CR ;
Gold, PB ;
Goldberg, RW ;
Mueser, KT ;
McFarlane, WR ;
Shafer, MS ;
Blankertz, LE ;
Dudek, K ;
Razzano, LA ;
Grey, DD ;
Burke-Miller, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (05) :505-512
[6]  
Cook JA, 2006, J VOCAT REHABIL, V25, P71
[7]  
EHRENBERG RG, 2000, MODERN LAB EC THEORY
[8]   Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics [J].
Faries, Douglas ;
Ascher-Svanum, Haya ;
Zhu, Baojin ;
Correll, Christoph ;
Kane, John .
BMC PSYCHIATRY, 2005, 5 (1)
[9]   Correlates of long-term unemployment among inner-city adults with serious and persistent mental illness [J].
Goldberg, RW ;
Lucksted, A ;
McNary, S ;
Gold, JM ;
Dixon, L ;
Lehman, A .
PSYCHIATRIC SERVICES, 2001, 52 (01) :101-103
[10]   Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample [J].
Hamilton, SH ;
Edgell, ET ;
Revicki, DA ;
Breier, A .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (05) :245-255